GB8819453D0 - Production of bluetongue virus non-structural proteins using baculovirus expression vector - Google Patents

Production of bluetongue virus non-structural proteins using baculovirus expression vector

Info

Publication number
GB8819453D0
GB8819453D0 GB888819453A GB8819453A GB8819453D0 GB 8819453 D0 GB8819453 D0 GB 8819453D0 GB 888819453 A GB888819453 A GB 888819453A GB 8819453 A GB8819453 A GB 8819453A GB 8819453 D0 GB8819453 D0 GB 8819453D0
Authority
GB
United Kingdom
Prior art keywords
production
expression vector
structural proteins
baculovirus expression
bluetongue virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888819453A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROY P
Original Assignee
ROY P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROY P filed Critical ROY P
Priority to GB888819453A priority Critical patent/GB8819453D0/en
Publication of GB8819453D0 publication Critical patent/GB8819453D0/en
Priority to PCT/GB1989/000939 priority patent/WO1990002186A1/en
Priority to EP89909839A priority patent/EP0431038A1/en
Priority to ZA896202A priority patent/ZA896202B/xx
Priority to AU41988/89A priority patent/AU4198889A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB888819453A 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector Pending GB8819453D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB888819453A GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector
PCT/GB1989/000939 WO1990002186A1 (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
EP89909839A EP0431038A1 (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
ZA896202A ZA896202B (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
AU41988/89A AU4198889A (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819453A GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector

Publications (1)

Publication Number Publication Date
GB8819453D0 true GB8819453D0 (en) 1988-09-21

Family

ID=10642209

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888819453A Pending GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector

Country Status (5)

Country Link
EP (1) EP0431038A1 (xx)
AU (1) AU4198889A (xx)
GB (1) GB8819453D0 (xx)
WO (1) WO1990002186A1 (xx)
ZA (1) ZA896202B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1324770A2 (en) * 2000-09-27 2003-07-09 The UAB Research Foundation Non-replicative particulate vaccine delivery system and methods of making and using same
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
KR101699142B1 (ko) 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 신규 항원-결합 폴리펩티드 및 이의 용도
CN103520735B (zh) 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
SG158148A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
JP2008525473A (ja) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド 修飾されたヒト成長ホルモン
MX2007007591A (es) 2004-12-22 2007-07-25 Ambrx Inc Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
CA2590429C (en) 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof
JP2008541769A (ja) 2005-06-03 2008-11-27 アンブレツクス・インコーポレイテツド 改善されたヒトインターフェロン分子及びそれらの使用
PT2339014E (pt) 2005-11-16 2015-10-13 Ambrx Inc Métodos e composições compreendendo aminoácidos não-naturais
WO2008030613A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
ES2465473T3 (es) 2006-09-08 2014-06-05 Ambrx, Inc. Transcripción de arnt supresor en células de vertebrado
KR20090060294A (ko) 2006-09-08 2009-06-11 암브룩스, 인코포레이티드 변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5547083B2 (ja) 2007-11-20 2014-07-09 アンブルックス,インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
CN103694337B (zh) 2008-02-08 2016-03-02 Ambrx公司 经修饰瘦素多肽和其用途
UA118536C2 (uk) 2008-07-23 2019-02-11 Амбркс, Інк. Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
NZ607477A (en) 2008-09-26 2014-09-26 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
KR101647164B1 (ko) 2008-09-26 2016-08-09 암브룩스, 인코포레이티드 변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도
CN107056929A (zh) 2009-12-21 2017-08-18 Ambrx 公司 经过修饰的猪促生长素多肽和其用途
CN107674121A (zh) 2009-12-21 2018-02-09 Ambrx 公司 经过修饰的牛促生长素多肽和其用途
MX346786B (es) 2010-08-17 2017-03-31 Ambrx Inc Polipeptidos de relaxina modificados y sus usos.
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
PL3412302T3 (pl) 2014-10-24 2021-11-02 Bristol-Myers Squibb Company Zmodyfikowane polipeptydy fgf-21 i ich zastosowania
CN110637027B (zh) 2017-02-08 2024-08-30 百时美施贵宝公司 包含药代动力学增强子的修饰的松弛素多肽及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591459B2 (en) * 1984-08-31 1989-12-07 Research Corporation cDNA probe for the detection of bluetongue virus
AP114A (en) * 1987-02-19 1991-02-01 Oxford Virology Ltd Production of bluetongue virus antigens using a baculovirus expression vector.

Also Published As

Publication number Publication date
AU4198889A (en) 1990-03-23
EP0431038A1 (en) 1991-06-12
WO1990002186A1 (en) 1990-03-08
ZA896202B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
GB8819453D0 (en) Production of bluetongue virus non-structural proteins using baculovirus expression vector
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
GB8610551D0 (en) Polypeptide & protein derivatives
NO180362C (no) Fremgangsmåte for fremstilling av cyklosporinholdige preparater
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
AU3756789A (en) Antagonists of viral transactivating proteins
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
AP8900114A0 (en) Expression of hiv binding proteins
ZA875633B (en) Recombinant htlv-iii proteins and uses thereof
AP8800083A0 (en) Production of bluetongue virus antigens using a baculovirus expression vector
AU5567090A (en) Purification of proteins employing ctap-iii fusions
ZA895460B (en) Novel proteins
AU2943389A (en) Enhanced production of cellular proteins using butyrate
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
YU219289A (en) Recombinant hybride proteins of interleucine-2
GB8817161D0 (en) Modified proteins
GB2193206B (en) Preparation of taurine-containing peptides
IE883483L (en) Expression of hiv proteins
EP0323846A3 (en) Process of preparing thiamphenicol
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
IE881525L (en) Preparation of protein
IE881482L (en) Recombinant htlv-iii proteins
GB8608182D0 (en) Production of proteins
ZA88849B (en) Production of bluetongue virus antigens using a baculovirus expression vector
ZA893263B (en) Production of polypeptides